Related Experiment Video

Updated: Apr 11, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
09:54

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats

Published on: March 23, 2018

8.4K

Myocardial injury and protection related to cardiopulmonary bypass

Stefan De Hert1, Anneliese Moerman1

  • 1Department of Anaesthesiology, Ghent University Hospital, Ghent University, Ghent B-9000, Belgium.

Best Practice & Research. Clinical Anaesthesiology
|June 11, 2015
PubMed

Insights

Cardiopulmonary bypass during heart surgery causes myocardial ischemia and reperfusion injury. This review explores strategies to mitigate this damage, improving patient outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Physiology

Background:

  • Cardiac surgery using cardiopulmonary bypass temporarily isolates the heart, leading to myocardial ischemia.
  • Reperfusion following ischemia can exacerbate tissue damage and organ dysfunction, known as ischemia-reperfusion injury.

Purpose of the Study:

  • To review the pathophysiology of myocardial injury associated with cardiopulmonary bypass.
  • To summarize therapeutic strategies for modulating ischemia-reperfusion injury in this context.

Main Methods:

  • Literature review of studies on cardiopulmonary bypass and myocardial injury.
  • Analysis of the mechanisms underlying ischemia-reperfusion injury.
  • Synthesis of current and potential therapeutic interventions.

Main Results:

  • Cardiopulmonary bypass is an established cause of myocardial ischemia and subsequent reperfusion injury.
  • Various strategies exist to attenuate ischemia-reperfusion injury, though their clinical efficacy varies.
  • Understanding the pathophysiology is key to developing effective treatments.

Conclusions:

  • Myocardial ischemia-reperfusion injury is a significant concern during cardiopulmonary bypass.
  • Targeting specific pathways involved in the injury process holds promise for therapeutic development.
  • Further research is needed to optimize protective strategies for patients undergoing cardiac surgery.

Keywords:
cardioprotectioncardiopulmonary bypassconditioningheartischemia–reperfusion injurymyocardium

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.5K
Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

12.2K

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
435
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
681
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
485
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.0K